Patrick Forde
@FordePatrick
Followers
6K
Following
7K
Media
350
Statuses
3K
Lung cancer & Mesothelioma. Immunotherapy believer. 🇮🇪 🇺🇸
Joined June 2019
RT @StephenVLiu: Just in time for the new academic year - 50 years of progress in NSCLC in this review article @JTOonline led by @DrJNaidoo….
0
15
0
Now published & open soon in 🇮🇪 Trial in progress that will answer q of neoadj only vs. periop immunotherapy for lung cancer! ETOP 25-23 ADOPT-lung: Phase III trial to evaluate adj durvalumab after neoadj chemo plus durva in pts w resectable NSCLC. #lcsm
0
9
51
Active agent, response rate 46% with more importantly a better side effect profile than most other options. FDA grants accelerated approval to sunvozertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations | FDA
2
6
29
RT @oncologytube: ✅CheckMate 816 @ASCO 2025 Update! .💊Neoadjuvant nivolumab raised 5-yr NSCLC survival (65% vs 55%). 💉 pCR patients: no lu….
0
2
0
RT @LuisRaezMD: Our @IASLC @ASCO highlights webinar is starting now with: NEOADAURA Jamie Chaft, CM 816 @FordePatrick .plasma-guided chemoI….
0
3
0
Starting now! First up Dr. Paz Vellanki from @FDAOncology with a regulatory perspective on neoadjuvant and perioperative clinical trial design.
Tomorrow is the #SITC Summit on the Future of Neoadjuvant Clinical Trial Design, which will discuss the recent advances in clinical trials for resectable tumors. The Neoadjuvant Clinical Trial Design Working Group is chaired by Patrick Forde, MD. Register:
0
1
11
Looking forward to an outstanding virtual summit on a hot topic - designing the newest clinical trials in earlier stage cancers that can be removed by surgery. Truly world leading panel to discuss key areas in this rapidly changing field. Join us for free online! @sitcancer #lcsm.
Tomorrow is the #SITC Summit on the Future of Neoadjuvant Clinical Trial Design, which will discuss the recent advances in clinical trials for resectable tumors. The Neoadjuvant Clinical Trial Design Working Group is chaired by Patrick Forde, MD. Register:
1
9
39
RT @g_mountzios: Missed #ASCO25 or want to digest the most important lung cancer trials?. Watch the @ASCO highlights webinar by @IASLC Educ….
0
7
0
Outstanding news for cancer care in Ireland, @CancerInstIRE is the first comprehensive cancer centre in the country! A unique & enduring partnership between Trinity College, 1st ranked university in Ireland @tcddublin & Ireland’s largest hospital @stjamesdublin !.
The Trinity St James’s Cancer Institute has become the first & only cancer centre in Ireland to be accredited as a Comprehensive Cancer Centre. This achievement marks a significant undertaking by @tcddublin & @stjamesdublin who jointly established the @CancerInstIRE.
0
6
48
RT @LungSummit: 📢 We're excited to welcome you today at 5:30 PM CEST for a deep dive into IO in #NSCLC. @peters_solange, @FordePatrick &….
0
8
0
RT @StephenVLiu: Beautiful review on neoadjuvant immunotherapy across tumor types & how we can further refine delivery and develop biomarke….
0
25
0
Looking forward to a challenging online debate on the merits of neoadjuvant vs perioperative immunotherapy with @JordiRemon tomorrow Wed June 25! Chaired by @peters_solange it should be a great event, join us at 16.30 CET, 15.30 Dublin/London 10.30 US East Coast, #lcsm.
📢 Mark your calendars!. @peters_solange teams up with @JordiRemon and @FordePatrick for a roundtable on the evolving landscape of Immunotherapies in Non-Small Cell Lung Cancer #NSCLC treatment. ⏰ Wednesday, 25th June 2025 at 5:30 PM CEST. Sign up and join the conversation ⬇️.
9
5
31
RT @HenningWillers: #ELIXR25 Early-Stage #LungCancer Conference in beautiful #Montreal🇨🇦organized by @DoctorJSpicer @mcgillu & Team was mul….
0
8
0
RT @HenningWillers: Uh oh 😅 we surrender to 🇨🇦.#elixr25.@maraantonoff @FordePatrick @CJTsaiMDPhD @DoctorJSpicer @DrJNaidoo @pompili_cecili….
0
5
0
RT @tcddublin: Trinity climbs to 75th place in 2026 QS @worlduniranking up 12 places from last year, its highest ranking in a decade. The i….
0
24
0
RT @DrJNaidoo: Congrats @DavidOReilly2 on the PLAN trial: plasma-first liquid biopsy (LB) v tissue (TB) for NSCLC in🇮🇪 @ejcancer:.- 138pts….
0
23
0
RT @gerryhanna: Interested in working with Ireland's largest radiation oncology team?. Join a dynamic☢️team at St Luke's Radiation Oncology….
0
12
0
RT @MartinBarr10: 🚨Delighted to share our comprehensive & timely review published in @JTOonline. Collaborative teamwork by members of the….
0
4
0